{"product_id":"2023-world-coagulation-testing-market-in-98-countries-hemostasis-analyzers-and-consumables-2022-supplier-shares-2022-2027-segment-volume-and-sales-forecasts-for-over-40-coagulation-assays-opportunities-for-suppliers-molecular-chromogenic-and-immu","title":"2023 World Coagulation Testing Market in 98 Countries - Hemostasis Analyzers and Consumables - 2022 Supplier Shares, 2022-2027 Segment Volume and Sales Forecasts for over 40 Coagulation Assays, Opportunities for Suppliers - Molecular, Chromogenic and Immu","description":"\u003cp\u003e2023 World Coagulation Testing Market in 98 Countries - Hemostasis Analyzers and Consumables - 2022 Supplier Shares, 2022-2027 Segment Volume and Sales Forecasts for over 40 Coagulation Assays, Opportunities for Suppliers - Molecular, Chromogenic and Immunodiagnostic Hemostasis Tests - Growth Strategies, Latest Technologies, Instrumentation Pipeline\u003c\/p\u003e\n\n\u003cp\u003eThis new 98-country survey from LeadingMarketResearch.com provides granular data and analysis not available from any other source.\u003c\/p\u003e\n\n\u003cp\u003eThe report explores business and technological trends; provides test volume and sales forecasts for 40 hemostasis procedures, as well as sales and market shares of leading competitors; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.\u003c\/p\u003e\n\n\u003cp\u003eRationale\u003c\/p\u003e\n\n\u003cp\u003eThe growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.\u003c\/p\u003e\n\n\u003cp\u003eNew specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.\u003c\/p\u003e\n\n\u003cp\u003eCoagulation Tests Analyzed in the Report\u003c\/p\u003e\n\n\u003cp\u003eActivated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor\/Pre-Kallikrein Factor Activation, Heparin\/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Lupus Anticoagulants, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function\/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Sickle Cell, TEG, Thrombin Time, Von Willebrand's Factor Fav\/Ag, and others.\u003c\/p\u003e\n\n\u003cp\u003eGeographic Regions and Countries\u003c\/p\u003e\n\n\u003cp\u003eAsia-Pacific\u003c\/p\u003e\n\n\u003cp\u003eAustralia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam\u003c\/p\u003e\n\n\u003cp\u003eEurope\u003c\/p\u003e\n\n\u003cp\u003eAlbania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine\u003c\/p\u003e\n\n\u003cp\u003eLatin America\u003c\/p\u003e\n\n\u003cp\u003eArgentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela\u003c\/p\u003e\n\n\u003cp\u003eMiddle East\u003c\/p\u003e\n\n\u003cp\u003eBahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003c\/p\u003e\n\n\u003cp\u003eCanada, Mexico, USA\u003c\/p\u003e\n\n\u003cp\u003eSales and Market Share Analysis\u003c\/p\u003e\n\n\u003cp\u003e- Sales and market shares of instrument and reagent suppliers in major countries.\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Assessments\u003c\/p\u003e\n\n\u003cp\u003e- Extensive strategic profiles of major suppliers and emerging market entrants.\u003c\/p\u003e\n\n\u003cp\u003eMarket Segmentation Analysis\u003c\/p\u003e\n\n\u003cp\u003e- Comprehensive market segmentation analysis in major countries, including:\u003c\/p\u003e\n\n\u003cp\u003e- Hospitals\u003c\/p\u003e\n\n\u003cp\u003e- Commercial\/Private Laboratories\u003c\/p\u003e\n\n\u003cp\u003e- Physician Offices\u003c\/p\u003e\n\n\u003cp\u003e- Ambulatory Care Centers\u003c\/p\u003e\n\n\u003cp\u003e- Test volume forecasts for over 40 major procedures.\u003c\/p\u003e\n\n\u003cp\u003eCurrent and Emerging Products\u003c\/p\u003e\n\n\u003cp\u003e- Review of established and emerging procedures.\u003c\/p\u003e\n\n\u003cp\u003e- Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.\u003c\/p\u003e\n\n\u003cp\u003eTechnology Review\u003c\/p\u003e\n\n\u003cp\u003e- Analysis of current and emerging technologies and their potential market applications.\u003c\/p\u003e\n\n\u003cp\u003e- Companies developing or marketing new technologies and products by test.\u003c\/p\u003e\n\n\u003cp\u003eStrategic Recommendations\u003c\/p\u003e\n\n\u003cp\u003e- Product development and business expansion opportunities with significant market appeal.\u003c\/p\u003e\n\n\u003cp\u003e- “Ideal” product models with tentative prices and operating characteristics.\u003c\/p\u003e\n\n\u003cp\u003e- Alternative market penetration strategies for instrument and reagent suppliers. - Potential market entry barriers and risks.\u003c\/p\u003e\n\n\u003cp\u003ePlease note: The delivery time for the electronic version of this report is between 1-3 business days to allow the preparation of an updated version prior to dispatch.\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"March, 2023 \/ - \/ MCW16228925","offer_id":47646896423218,"sku":null,"price":22200.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/2023-world-coagulation-testing-market-in-98-countries-hemostasis-analyzers-and-consumables-2022-supplier-shares-2022-2027-segment-volume-and-sales-forecasts-for-over-40-coagulation-assays-opportunities-for-suppliers-molecular-chromogenic-and-immu","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}